𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Pramipexole versus Levodopa in Patients with Early Parkinson's Disease: Effect on Generic and Disease-Specific Quality of Life

✍ Scribed by Katia Noyes; Andrew W. Dick; Robert G. Holloway

Book ID
109078543
Publisher
John Wiley and Sons
Year
2006
Tongue
English
Weight
186 KB
Volume
9
Category
Article
ISSN
1098-3015

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Quality of life in early Parkinson's dis
Quality of life in early Parkinson's disease treated with levodopa/carbidopa/entacapone
✍ Victor S.C. Fung; Lilie Herawati; Ying Wan πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 172 KB

## Abstract We aimed to investigate whether treatment with levodopa/carbidopa/entacapone when compared with levodopa/carbidopa improves quality of life in Parkinson's disease (PD) patients with no or minimal, nondisabling motor fluctuations. This is a multicenter, randomized, double‐blind study. On

Rasagiline improves quality of life in p
Rasagiline improves quality of life in patients with early Parkinson's disease
✍ Kevin M. Biglan; Steven Schwid; Shirley Eberly; Karen Blindauer; Stanley Fahn; T πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 164 KB πŸ‘ 1 views

The objective of this study was to determine the effects of rasagiline as monotherapy on quality of life (QOL) in patients with early Parkinson's disease (PD). Rasagiline, a potent, second-generation, irreversible, selective monoamine oxidase B inhibitor improves PD symptoms in patients with early P